M&T Bank Corp Sells 3,538 Shares of HealthEquity, Inc. (NASDAQ:HQY)

M&T Bank Corp trimmed its position in HealthEquity, Inc. (NASDAQ:HQY) by 7.2% during the fourth quarter, HoldingsChannel.com reports. The firm owned 45,909 shares of the company’s stock after selling 3,538 shares during the quarter. M&T Bank Corp’s holdings in HealthEquity were worth $4,405,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Assetmark Inc. grew its position in shares of HealthEquity by 3.5% in the fourth quarter. Assetmark Inc. now owns 4,702 shares of the company’s stock valued at $451,000 after purchasing an additional 158 shares during the last quarter. Carrera Capital Advisors lifted its stake in shares of HealthEquity by 42.5% in the 4th quarter. Carrera Capital Advisors now owns 22,611 shares of the company’s stock valued at $2,170,000 after acquiring an additional 6,743 shares during the last quarter. Keybank National Association OH bought a new position in shares of HealthEquity in the 4th quarter valued at $393,000. Charles Schwab Investment Management Inc. lifted its stake in shares of HealthEquity by 2.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company’s stock valued at $104,280,000 after acquiring an additional 25,004 shares during the last quarter. Finally, State of Michigan Retirement System lifted its stake in shares of HealthEquity by 0.5% in the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock valued at $1,988,000 after acquiring an additional 100 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the subject of several analyst reports. Barrington Research raised their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. BTIG Research lifted their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. JMP Securities lifted their price target on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Royal Bank of Canada lifted their price target on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Finally, The Goldman Sachs Group began coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $113.54.

HealthEquity Stock Performance

HealthEquity stock opened at $100.58 on Friday. The company’s 50-day moving average price is $105.71 and its 200-day moving average price is $94.21. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market cap of $8.72 billion, a PE ratio of 92.28, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the previous year, the firm earned $0.40 EPS. On average, equities research analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 39,000 shares of company stock valued at $3,895,788. Company insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.